4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001689375-24-000064
President, Research & Develop. sold 18,219 shares at an average $18.62 ($339,281)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sethuraman Natarajan President, Research & Develop. | 2024-11-04 | Sale 10b5-1 | −749 | $18.02 | $13,498 | 182,467 | D |
| Sethuraman Natarajan President, Research & Develop. | 2024-11-05 | Sale 10b5-1 | −5,171 | $18.18 | $94,006 | 177,296 | D |
| Sethuraman Natarajan President, Research & Develop. | 2024-11-06 | Sale 10b5-1 | −9,554 | $18.71 | $178,752 | 167,742 | D |
| Sethuraman Natarajan President, Research & Develop. | 2024-11-06 | Sale 10b5-1 | −2,745 | $19.32 | $53,024 | 164,997 | D |
| Open-market sales · 18,219 sh · avg $18.62 · $339,281 | |||||||
Loading xslF345X05/wk-form4_1730929001.xml…